首页> 外国专利> Leukocyte and / or hematopoietic stem / progenitor cell mobilization agent

Leukocyte and / or hematopoietic stem / progenitor cell mobilization agent

机译:白细胞和/或造血干/祖细胞动员剂

摘要

Disclosed is a mobilize of a leukocyte and/or a hematopoietic stem/progenitor cell which is economically advantageous compared to the administration of a G-CSF preparation and causes reduced adverse side effects. A mobilizer of a leukocyte means an agent for increasing the number of leukocytes, and a mobilizer of a hematopoietic setm/progenitor cell means an agent for mobilizing a hematopoietic stem/progenitor cell from the marrow to the peripheral blood. Particularly, disclosed is a pharmaceutical preparation which is reduced in such adverse side effects (e.g., head ache, fever, bone ache) that may be caused when a G-CSF preparation is administered as a mobilizer of a hematopoietic stem/progenitor cell to the peripheral blood. A pharmaceutical preparation comprising an N-acetylneuraminate sulfate ester or an N-acetylneuraminate homopolymer sulfate ester or a pharmaceutically acceptable salt thereof. When the pharmaceutical preparation is administered, an effect of increasing the number of leukocytes and an effect of mobilizing hematopoietic stem/progenitor cells to the peripheral blood can be observed.
机译:公开了白细胞和/或造血干/祖细胞的动员,与施用G-CSF制剂相比在经济上是有利的,并且减少了不利的副作用。白细胞的动员是指增加白细胞数目的试剂,造血的setm /祖细胞的动员是指将骨髓的造血干/祖细胞动员至外周血的试剂。特别地,公开了一种药物制剂,该药物制剂减少了当将G-CSF制剂作为造血干/祖细胞的动员剂施用给小鼠时可能引起的这种不利副作用(例如,头痛,发烧,骨痛)。外周血。药物制剂,其包含N-乙酰神经氨酸硫酸酯酯或N-乙酰神经氨酸均聚物硫酸酯或其药学上可接受的盐。当施用药物制剂时,可以观察到增加白细胞数目的效果和将造血干/祖细胞动员至外周血的效果。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号